Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.


The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1987 1
1992 1
2002 2
2008 1
2009 1
2010 1
2011 1
2012 1
2014 1
2015 1
2016 1
2018 1
2021 1
2022 0
Text availability
Article attribute
Article type
Publication date

Search Results

12 results
Results by year
Filters applied: . Clear all
Page 1
Did you mean belch, j (414 results)?
Contemporary Management of Severe Symptomatic Aortic Stenosis.
Eugène M, Duchnowski P, Prendergast B, Wendler O, Laroche C, Monin JL, Jobic Y, Popescu BA, Bax JJ, Vahanian A, Iung B; EORP VHD II Registry Investigators Group. Eugène M, et al. J Am Coll Cardiol. 2021 Nov 30;78(22):2131-2143. doi: 10.1016/j.jacc.2021.09.864. J Am Coll Cardiol. 2021. PMID: 34823655 Free article.
18F-FDG PET/CT in the diagnosis of prosthetic valve endocarditis.
Vidal V, Albiach C, Gradolí J, Pérez JL, Montagud V, Belchí J, Morell S, Fácila L. Vidal V, et al. Among authors: belchi j. Rev Port Cardiol (Engl Ed). 2018 Aug;37(8):717.e1-717.e5. doi: 10.1016/j.repc.2017.05.014. Epub 2018 Jun 19. Rev Port Cardiol (Engl Ed). 2018. PMID: 29934214 Free article. English, Portuguese.
[Psychosis and mental retardation].
Barcia D, Ruiz ME, Salorio P, Martínez I, Belchi J. Barcia D, et al. Among authors: belchi j. Arch Neurobiol (Madr). 1987 Jul-Aug;50(4):243-53. Arch Neurobiol (Madr). 1987. PMID: 3310951 Review. Spanish. No abstract available.
Thrombin-receptor antagonist vorapaxar in acute coronary syndromes.
Tricoci P, Huang Z, Held C, Moliterno DJ, Armstrong PW, Van de Werf F, White HD, Aylward PE, Wallentin L, Chen E, Lokhnygina Y, Pei J, Leonardi S, Rorick TL, Kilian AM, Jennings LH, Ambrosio G, Bode C, Cequier A, Cornel JH, Diaz R, Erkan A, Huber K, Hudson MP, Jiang L, Jukema JW, Lewis BS, Lincoff AM, Montalescot G, Nicolau JC, Ogawa H, Pfisterer M, Prieto JC, Ruzyllo W, Sinnaeve PR, Storey RF, Valgimigli M, Whellan DJ, Widimsky P, Strony J, Harrington RA, Mahaffey KW; TRACER Investigators. Tricoci P, et al. N Engl J Med. 2012 Jan 5;366(1):20-33. doi: 10.1056/NEJMoa1109719. Epub 2011 Nov 13. N Engl J Med. 2012. PMID: 22077816 Free article. Clinical Trial.
Carbohydrate Antigen-125-Guided Therapy in Acute Heart Failure: CHANCE-HF: A Randomized Study.
Núñez J, Llàcer P, Bertomeu-González V, Bosch MJ, Merlos P, García-Blas S, Montagud V, Bodí V, Bertomeu-Martínez V, Pedrosa V, Mendizábal A, Cordero A, Gallego J, Palau P, Miñana G, Santas E, Morell S, Llàcer A, Chorro FJ, Sanchis J, Fácila L; CHANCE-HF Investigators. Núñez J, et al. JACC Heart Fail. 2016 Nov;4(11):833-843. doi: 10.1016/j.jchf.2016.06.007. Epub 2016 Aug 10. JACC Heart Fail. 2016. PMID: 27522630 Free article. Clinical Trial.
Prognostic effect of carbohydrate antigen 125-guided therapy in patients recently discharged for acute heart failure (CHANCE-HF). Study design.
Núñez J, Merlos P, Fácila L, Llàcer P, Bosch MJ, Bertomeu-Martínez V, García-Blas S, Montagud V, Pedrosa V, Mendizábal A, Cordero A, Miñana G, Sanchis J, Bertomeu-González V; CHANCE-HF Investigators. Núñez J, et al. Rev Esp Cardiol (Engl Ed). 2015 Feb;68(2):121-8. doi: 10.1016/j.rec.2014.03.018. Epub 2014 Aug 10. Rev Esp Cardiol (Engl Ed). 2015. PMID: 25623430 Clinical Trial.
Dual-chamber defibrillators reduce clinically significant adverse events compared with single-chamber devices: results from the DATAS (Dual chamber and Atrial Tachyarrhythmias Adverse events Study) trial.
Almendral J, Arribas F, Wolpert C, Ricci R, Adragao P, Cobo E, Navarro X, Quesada A; DATAS Steering Committee; DATAS Writing Committee; DATAS Investigators. Almendral J, et al. Europace. 2008 May;10(5):528-35. doi: 10.1093/europace/eun072. Epub 2008 Apr 7. Europace. 2008. PMID: 18390985 Clinical Trial.
Dual-chamber implantable cardioverter defibrillators reduce clinical adverse events related to atrial fibrillation when compared with single-chamber defibrillators: a subanalysis of the DATAS trial.
Ricci RP, Quesada A, Almendral J, Arribas F, Wolpert C, Adragao P, Zoni-Berisso M, Navarro X, DeSanto T, Grammatico A, Santini M; DATAS study Investigators. Ricci RP, et al. Europace. 2009 May;11(5):587-93. doi: 10.1093/europace/eup072. Europace. 2009. PMID: 19401341 Clinical Trial.
12 results